Free Daily Podcast Summary
Business Of Biotech: Daily Summaries Delivered
by Ben Comer
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries.
Latest Episodes
The most recent episodes — sign up to get AI-powered summaries of each one.
- Yesterday55 min
Drug Launch Success In A Changing Commercial Landscape With ACMA's William Soliman, Ph.D.
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, William Soliman, Founder and CEO of the Accreditation Council for Medical Affairs (ACMA), and Founder and CIO of White Manna Capital Partners, talks about why biotech drug launches so often miss expectations, and how to build an integrated commercialization plan that holds up with physicians, patients, and payers. William also describes the evolution in medical affairs, why standards and...
- 1 weeks ago1h 24m
The Editors' Roundtable: A Midyear Look At The 2026 Life Sciences Industry
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Tyler Menichiello, chief editor at Bioprocess Online, host of the Better Biopharma podcast, and my Life Science Connect (LSC) colleague, convenes the broader LSC editorial team once again for a midyear discussion on what's happening now in the life sciences industry, and what's to come in the second half of the year. Topics include AI manufacturing regulations and navigating supply chain...
- 2 weeks ago49 min
Derisking CNS Drug Development With Tortugas Neuroscience's Jeff Jonas, M.D.
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Jeff Jonas, M.D., CEO of Tortugas Neuroscience, talks about the company's April 2026 launch and how in-licensed development assets were chosen. Jeff explains his strategy of chasing fast proof of safety and efficacy in humans, not animals, and talks about what product differentiation looks like in brain disorders, from adjusting indication targets to conducting head-to-head trials. He al...
- 3 weeks ago55 min
Rare Disease Drug Commercialization With Zevra Therapeutics' Neil McFarlane
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Neil McFarlane, CEO at Zevra Therapeutics, talks about transitioning to a focused rare disease company through acquisitions, and building out a commercial organization. Neil explains the importance of working with rare disease patient advocacy groups, using AI to analyze electronic health records and claims data to identify and diagnose patients with Niemann-Pick disease type C, and adap...
- 4 weeks ago50 min
Scaling Manufacturing For Personalized Cell Therapies With Cellino's Marinna Madrid, Ph.D.
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Marinna Madrid, Ph.D., Cofounder, Board Member, Chief Product and Regulatory Officer at Cellino, talks about scaling up an automated manufacturing process she co-invented for personalized autologous induced pluripotent stem cell (iPSC) therapies using laser-activated substrates and AI. Marinna describes her work with industry groups to improve regulatory guidelines, Cellino's partnership...
- May 11, 202654 min
Building A New Antibody Discovery Platform With Infinimmune's Wyatt McDonnell, Ph.D.
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Wyatt McDonnell, Ph.D., cofounder and CEO at Infinimmune, talks about how single-cell biology and computational rigor led to the formation of Infinimmune, and a new way to discover human-derived antibody drugs. Wyatt explains Infinimmune's 'discovered in humans' antibody discovery platform, how the company was launched and initially funded, and how Infinimmune landed a Merck collaboratio...
- May 4, 202655 min
From Partnered ASO Therapies To A Wholly-Owned Pipeline With Ionis's Brett Monia, Ph.D.
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Brett Monia, Ph.D., CEO at Ionis Pharmaceuticals, talks about how antisense oligonucleotides (ASO) graduated from a late-1980s lab concept to real RNA-targeting medicines, and why Ionis stuck with a difficult modality despite multiple setbacks. Brett describes the company's shift from a partner-first model to building a wholly-owned pipeline, commercial function, and an expanded manufact...
- Apr 27, 202647 min
Implementing A New CEO Strategy With NervGen's Adam Rogers, M.D. And Rich Macary
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, we talk with NervGen leaders Adam Rogers, M.D., and Rich Macary about NVG-291, a daily neuroreparative peptide designed to restore function in patients with spinal cord injuries. Adam talks about his strategy for the company after becoming CEO last July, including moving company trading from Canada's TSX Venture Exchange to the NASDAQ for better visibility, and making key hires for growt...
Get Business Of Biotech summaries in your inbox
Free AI-powered daily recaps. Key takeaways, quotes, and mentions — in a 5-minute read.
Get Free Summaries →Free forever for up to 3 podcasts. No credit card required.
You Might Also Like
Listeners also like.
Founder's Story
Real founders share raw stories of building, scaling, and leading companies, revealing the grit and purpose behind entrepreneurial success.
BiggerPockets Business Podcast
Real entrepreneurs share practical advice on starting, growing, and selling businesses, covering hiring, marketing, and raising capital.
DTC POD: How The Best Brands Are Built
Explores how direct-to-consumer brands are built, from startup to growth, through interviews with founders, marketers, and industry experts.
Right About Now - Legendary Business Advice
Real talk from business founders and entrepreneurs about building companies, lessons learned, and what actually works in real-world ventures.
Mind The Business: Small Business Success Stories
Small business owners share real stories about starting, growing, and navigating the challenges of entrepreneurship.
The Entrepreneur DNA
Entrepreneurs share lessons on building businesses and personal growth through real experiences and mistakes.
The Restless Ones
Executives at the intersection of technology and business discuss innovation, leadership, and driving change in fast-evolving industries.
Business Movers
True stories of visionary business leaders and the bold risks, successes, and failures that shaped iconic companies and changed the world.
TBPN
A daily live tech talk show featuring interviews with major figures in Silicon Valley and the tech industry.
Drug Story
Each episode explores the unexpected stories behind prescription drugs and the business of treating illness.
The AI in Business Podcast
Executives discuss practical AI adoption in business through interviews focused on strategy, use-cases, and ROI.
The Bottom Line
Evan Davis interviews business leaders about major industry challenges, leadership decisions, and the realities of running organizations.
About Business Of Biotech
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries.
Customized Recaps
AI-powered recaps with compact key takeaways, quotes, and insights.
Straight to Your Inbox
Get key takeaways from Business Of Biotech in a 5-minute read.
Save Hours Every Week
Stay current on your favorite podcasts without falling behind.
Frequently Asked Questions
What is Podzilla's Business Of Biotech daily summary?
It's a free AI-powered email that summarizes new episodes of Business Of Biotech as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
How does the Business Of Biotech podcast summary work?
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
Is this an official Business Of Biotech product?
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by Ben Comer.
Can I get summaries of other podcasts too?
Absolutely! The free plan covers up to 3 podcasts. Upgrade to Pro for 15, or Premium for 50. Browse our full catalog at /podcasts.
How often does Business Of Biotech release new episodes?
Business Of Biotech publishes weekly. Our AI generates a summary within hours of each new episode.
What topics does Business Of Biotech cover?
Business Of Biotech covers topics including Science, Business, Management, Life Sciences. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Start getting Business Of Biotech summaries tomorrow morning.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.